Terns Pharmaceuticals Inc (TERN) — Financial Flexibility Index
Terns Pharmaceuticals Inc (TERN) has a Financial Flexibility Index of -1.12x as of September 2025. Free cash flow of $-19.77 Million (operating CF $-19.77 Million minus capex $0.00) represents -1% of total liabilities ($17.59 Million). Check TERN PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Terns Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Terns Pharmaceuticals Inc across 7 annual periods. See Terns Pharmaceuticals Inc (TERN) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Terns Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Terns Pharmaceuticals Inc. For the full company profile including market capitalisation, see TERN market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.87x | $-69.97 Million | $-70.02 Million | $18.06 Million | ▲ +24.3% |
| 2023 | -5.12x | $-67.34 Million | $-67.39 Million | $13.15 Million | ▼ -5.7% |
| 2022 | -4.84x | $-48.83 Million | $-49.11 Million | $10.08 Million | ▲ +9.3% |
| 2021 | -5.34x | $-41.49 Million | $-41.83 Million | $7.77 Million | ▼ -333.1% |
| 2020 | -1.23x | $-29.23 Million | $-29.81 Million | $23.70 Million | ▲ +89.5% |
| 2019 | -11.71x | $-65.32 Million | $-66.22 Million | $5.58 Million | ▼ -1006.0% |
| 2018 | -1.06x | $-17.83 Million | $-18.07 Million | $16.84 Million | — |